Exploring the diversity and metabolic potential of actinomycetes from temperate marine sediments from Newfoundland, Canada

Marine sediments from Newfoundland, Canada were explored for biotechnologically promising Actinobacteria using culture-independent and culture-dependent approaches. Culture-independent pyrosequencing analyses uncovered significant actinobacterial diversity (H′—2.45 to 3.76), although the taxonomic diversity of biotechnologically important actinomycetes could not be fully elucidated due to limited sampling depth. Assessment of culturable actinomycete diversity resulted in the isolation of 360 actinomycetes representing 59 operational taxonomic units, the majority of which (94 %) were Streptomyces. The biotechnological potential of actinomycetes from NL sediments was assessed by bioactivity and metabolomics-based screening of 32 representative isolates. Bioactivity was exhibited by 41 % of isolates, while 11 % exhibited unique chemical signatures in metabolomics screening. Chemical analysis of two isolates resulted in the isolation of the cytotoxic metabolite 1-isopentadecanoyl-3β-d-glucopyranosyl-X-glycerol from Actinoalloteichus sp. 2L868 and sungsanpin from Streptomyces sp. 8LB7. These results demonstrate the potential for the discovery of novel bioactive metabolites from actinomycetes isolated from Atlantic Canadian marine sediments

Assessing accumulation and biliary excretion of naphthenic acids in yellow perch exposed to oil sands-affected waters

Naphthenic acids are known to be the most prevalent group of organic compounds in oil sands tailings-associated waters. Yellow perch (Perca flavescens) were exposed for four months to oil sands-influenced waters in two experimental systems located on an oil sands lease 30km north of Fort McMurray Alberta: the Demonstration Pond, containing oil sands tailings capped with natural surface water, and the South Bison Pond, integrating lean oil sands. Yellow perch were also sampled from three lakes: Mildred Lake that receives water from the Athabasca River, Sucker Lake, at the edge of oil sands extraction activity, and Kimowin Lake, a distant reference site. Naphthenic acids were measured in perch muscle tissue using gas chromatography-mass spectrometry (GC-MS). Bile metabolites were measured by GC-MS techniques and by high performance liquid chromatography (HPLC) with fluorescence detection at phenanthrene wavelengths. A method was developed using liquid chromatography-high resolution mass spectrometry (LC-HRMS) to evaluate naphthenic acids in bile. Tissue analysis did not show a pattern of naphthenic acids accumulation in muscle tissue consistent with known concentrations in exposed waters. Bile fluorescence and LC-HRMS methods were capable of statistically distinguishing samples originating from oil sands-influenced waters versus reference lakes. Although the GC-MS and HPLC fluorescence methods were correlated, there were no significant correlations of these methods and the LC-HRMS method. In yellow perch, naphthenic acids from oil sands sources do not concentrate in tissue at a measurable amount and are excreted through a biliary route. LC-HRMS was shown to be a highly sensitive, selective and promising technique as an indicator of exposure of biota to oil sands-derived naphthenic acids

Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK.

A recent study examined common genetic variants at the adiponectin locus (ADIPOQ) in two case-control colorectal cancer (CRC) series from the USA and reported a positive association between a single nucleotide polymorphism (SNP) in the 5' region of the gene (rs266729) and decreased disease risk. In an attempt to replicate the previously reported association, we examined data from two CRC genome-wide association studies based on the UK population. The first cohort comprised 931 familial colorectal tumour cases and 929 cancer-free controls. The second included 1216 individuals with Dukes stage B or C CRCs from two clinical trials and 1436 controls from the 1958 Birth Cohort. We tested associations between CRC risk and 82 SNPs in a region of 250 kb around the ADIPOQ gene; nine of these SNPs were located in the coding and promoter regions. None of the markers tested was significantly associated with CRC risk after correction for multiple testing under any of the models in any of the two cohorts. A meta-analysis of the data also failed to detect any association. We, therefore, failed to replicate an association between common variants at ADIPOQ and CRC risk in the UK, and suggest that the previous report is either population-specific or a false-positive result

An index of refractory organics /

Mode of access: Internet

Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer.

The common single-nucleotide polymorphism (SNP) rs3802842 at 11q23.1 has recently been reported to be associated with risk of colorectal cancer (CRC). To examine this association in detail we genotyped rs3802842 in eight independent case-control series comprising a total of 10 638 cases and 10 457 healthy individuals. A significant association between the C allele of rs3802842 and CRC risk was found (per allele OR = 1.17; 95% confidence interval [CI]: 1.12-1.22; P = 1.08 x 10(-12)) with the risk allele more frequent in rectal than colonic disease (P = 0.02). In combination with 8q21, 8q24, 10p14, 11q, 15q13.3 and 18q21 variants, the risk of CRC increases with an increasing numbers of variant alleles for the six loci (OR(per allele) = 1.19; 95% CI: 1.15-1.23; P(trend) = 7.4 x 10(-24)). Using the data from our genome-wide association study of CRC, LD mapping and imputation, we were able to refine the location of the causal locus to a 60 kb region and screened for coding changes. The absence of exonic mutations in any of the transcripts (FLJ45803, LOC120376, C11orf53 and POU2AF1) mapping to this region makes the association likely to be a consequence of non-coding effects on gene expression